Transcriptomics,Genomics

Dataset Information

0

Specific targeting of the common gamma chain blocks cooperative reprogramming of human tissue-resident cytotoxic T lymphocytes by IL-15 and IL-21


ABSTRACT: The common gamma chain (γc) is required for productive signaling by interleukin (IL)-15, IL-21 and IL-2, which are critically involved in immune activation and regulation. IL-21 and IL-15 are implicated in the pathogenesis of type-1 diabetes, graft-versus-host disease, and celiac disease (CeD), a gluten-mediated autoimmune-like enteropathy. Attempts to treat type-1 diabetes and graft-versus-host disease with biologics targeting one particular cytokine have failed. Both IL-15 and IL-21 have been suggested to drive activation of cytotoxic T cells (CTL) that are the effectors mediating tissue destruction in CeD and organ-specific autoimmune disorders. We show that the concomitant upregulation of IL-15 and IL-21 occurs only in full-blown CeD with villous atrophy. BNZ-2, a peptide that targets the γc, was able to block the cooperative IL-15/IL-21 mediated transcriptional activation of human tissue-resident intraepithelial CTL. Importantly, this inhibition was specific and did not interfere with IL-2 signaling, a cytokine with known immunoregulatory functions. Moreover, BNZ-2 blocked gluten-induced IFN-γ production in small intestinal organ cultures from CeD patients. These observations identify BNZ-2 as a therapeutic candidate for immune disorders in which IL-15 and IL-21 cooperate to induce CTL-mediated tissue damage. Overall design: Gene expression profiles of human tissue-resident IE-CTLs (both in vitro and ex vivo), before and after simulation with IL-15 and IL-21 (individually and in combination).

INSTRUMENT(S): Illumina HiSeq 4000 (Homo sapiens)

SUBMITTER: Alain Pacis  

PROVIDER: GSE120904 | GEO | 2018-10-06

REPOSITORIES: GEO

Similar Datasets

1000-01-01 | S-EPMC2736142 | BioStudies
2020-01-01 | S-EPMC7047598 | BioStudies
2013-01-01 | S-EPMC3732447 | BioStudies
2018-01-01 | S-EPMC6495055 | BioStudies
1000-01-01 | S-EPMC3111309 | BioStudies
1000-01-01 | S-EPMC5539112 | BioStudies
2018-01-01 | S-EPMC6050360 | BioStudies
2013-01-01 | S-EPMC3594487 | BioStudies
2017-01-01 | S-EPMC5484589 | BioStudies
1000-01-01 | S-EPMC4639966 | BioStudies